EMA — authorised 2 February 2021
- Marketing authorisation holder: XERIS PHARMACEUTICALS IRELAND LIMITED
- Status: approved
EMA authorised Glucagen on 2 February 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 2 February 2021.
XERIS PHARMACEUTICALS IRELAND LIMITED holds the EU marketing authorisation.